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Abstract 
Background: Biodiesel is a mixture of fatty acid short‑chain alkyl esters of different fatty acid carbon chain lengths. 
However, while fatty acid methyl or ethyl esters are useful biodiesel produced commercially, fatty acid esters with 
branched‑chain alcohol moieties have superior fuel properties. Crucially, this includes improved cold flow character‑
istics, as one of the major problems associated with biodiesel use is poor low‑temperature flow properties. Hence, 
microbial production as a renewable, nontoxic and scalable method to produce fatty acid esters with branched‑chain 
alcohol moieties from biomass is critical.
Results: We engineered Saccharomyces cerevisiae to produce fatty acid short‑ and branched‑chain alkyl esters, 
including ethyl, isobutyl, isoamyl and active amyl esters using endogenously synthesized fatty acids and alcohols. 
Two wax ester synthase genes (ws2 and Maqu_0168 from Marinobacter sp.) were cloned and expressed. Both enzymes 
were found to catalyze the formation of fatty acid esters, with different alcohol preferences. To boost the ability of S. 
cerevisiae to produce the aforementioned esters, negative regulators of the INO1 gene in phospholipid metabolism, 
Rpd3 and Opi1, were deleted to increase flux towards fatty acyl‑CoAs. In addition, five isobutanol pathway enzymes 
(Ilv2, Ilv5, Ilv3, Aro10, and Adh7) targeted into the mitochondria were overexpressed to enhance production of alcohol 
precursors. By combining these engineering strategies with high‑cell‑density fermentation, over 230 mg/L fatty acid 
short‑ and branched‑chain alkyl esters were produced, which is the highest titer reported in yeast to date.
Conclusions: In this work, we engineered the metabolism of S. cerevisiae to produce biodiesels in the form of fatty 
acid short‑ and branched‑chain alkyl esters, including ethyl, isobutyl, isoamyl and active amyl esters. To our knowl‑
edge, this is the first report of the production of fatty acid isobutyl and active amyl esters in S. cerevisiae. Our findings 
will be useful for engineering S. cerevisiae strains toward high‑level and sustainable biodiesel production.
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Background
Biodiesel is a mixture of fatty acid short-chain alkyl esters 
of different fatty acid carbon chain lengths. FAMEs (fatty 
acid methyl esters) and FAEEs (fatty acid ethyl esters) are 
used as commercial biodiesel and obtained via transes-
terification of vegetable oils with an alcohol (methanol or 
ethanol) with the aid of a catalyst. However, while FAMEs 
or FAEEs are useful alternative diesel fuels currently 
being used in the market, fatty acid esters with branched-
chain alcohol moieties have better fuel properties [1, 2]. 
Crucially, this includes improved cold flow characteris-
tics where cloud points and pour points are reduced, as 
one of the major problems associated with biodiesel use 
is poor low-temperature flow properties [3].
Baker’s yeast Saccharomyces cerevisiae, which is used 
for industrial scale bioethanol production, brewing and 
winemaking, is an important host for biotechnological 
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applications [4]. The ability to grow robustly and the 
abundance of genetic tools available for its manipula-
tion make yeast an ideal host microbe for engineering 
biofuel production. Various research groups have engi-
neered yeast for production of FAEEs by heterologous 
expression of an acyl-CoA: alcohol acyltransferase or 
wax ester synthase [5–11]. Five wax ester synthases, from 
Acinetobacter baylyi ADP1, Marinobacter hydrocarbono-
clasticus DSM 8798, Rhodococcus opacus PD630, Mus 
musculus C57BL/6 and Psychrobacter arcticus 273-4 
were expressed in yeast where wax ester synthase from 
M. hydrocarbonoclasticus DSM 8798 (ws2) was found 
to produce the most FAEEs (6.3  mg/L) [5]. Multiple 
metabolic engineering strategies were applied towards 
boosting the production of FAEEs in yeast. Abolishing 
protein kinase Snf1-dependent regulation of acetyl-CoA 
carboxylase Acc1 through Ser659 and Ser1157 muta-
tion increased FAEEs titers to 15.8 mg/L [6]. Elimination 
of non-essential fatty acid utilization pathways through 
deletion of acyl-CoA: sterol acyltransferases (encoded 
by ARE1 and ARE2), diacylglycerol acyltransferases 
(encoded by DGA1 and LRO1) and fatty acyl-CoA oxi-
dase (encoded by POX1) led to 17.2  mg/L FAEEs [7]. 
Integration of 6 copies of the ws2 expression cassette into 
the genome increased production of FAEEs to 34 mg/L, 
while further boosting of the fatty acyl-CoAs avail-
ability by acyl-CoA binding protein (encoded by ACB1) 
overexpression and NADPH supply by overexpression 
of bacterial NADP+-dependent glyceraldehyde-3-phos-
phate dehydrogenase (gapN) led to FAEEs production of 
48 mg/L [8].
On the other hand, only trace amounts of fatty acid 
isoamyl esters (FAIEs) and FAEEs were produced in an 
engineered yeast strain expressing wax ester synthase 
from A. baylyi ADP1 and with ARE1, ARE2, DGA1 and 
LRO1 disrupted [12, 13]. In addition, the metabolic engi-
neering of yeast to produce and accumulate fatty acid 
isobutyl esters (FABEs) and fatty acid active amyl esters 
(FAAEs) has not been reported. Here, we engineered 
yeast to produce fatty acid short- and branched-chain 
esters (FASBEs), including ethyl, isobutyl, active amyl 
and isoamyl esters, using endogenously synthesized fatty 
acids and alcohols (Fig. 1). First, two wax ester synthase 
genes (ws2 and Maqu_0168 from Marinobacter sp.) 
were cloned and expressed. Second, negative regulators 
of the INO1 gene in phospholipid metabolism, Rpd3 
and Opi1, were deleted. INO1 gene encodes for inositol-
3-phosphate synthase that makes inositol phosphates 
and inositol-containing phospholipids. As synthesis of 
phospholipids requires fatty acyl-CoAs as precursors, 
the removal of INO1 negative regulators may boost flux 
towards fatty acyl-CoAs-derived phospholipids and 
the abovementioned esters [14].The deletion of RPD3 
and OPI1 was shown previously to enable simultaneous 
increase of phospholipids and desired product 1-hexa-
decanol [15]. Third, isobutanol pathway enzymes (ace-
tolactate synthase Ilv2, ketoacid reductoisomerase Ilv5, 
dihydroxyacid dehydratase Ilv3, α-ketoacid decarboxy-
lase Aro10, and alcohol dehydrogenase Adh7) targeted 
into the mitochondria were overexpressed to boost pro-
duction of alcohol precursors. Ilv2, Ilv5 and Ilv3 are natu-
rally located in the mitochondria, whereas Aro10 and 
Adh7 were re-targeted to the mitochondria using N-ter-
minal fusion with mitochondria localization signal from 
subunit IV of the yeast cytochrome c oxidase (encoded 
by COX4) [16, 17]. Compartmentalization of this path-
way into the mitochondria enabled high-level production 
of branched-chain alcohols. Finally, by combining these 
engineering strategies with high-cell-density fermenta-
tion, over 230 mg/L FASBEs were produced, which rep-
resents the highest titer reported in yeast to date.
Results and discussion
Substrate preference of the wax ester synthases
To produce FASBEs in S. cerevisiae, a wax ester synthase 
gene needs to be expressed. The ws2 enzyme, which was 
selected as the best wax ester synthase for FAEEs pro-
duction in yeast [5], and the Maqu_0168 enzyme, which 
was shown in vitro to have high wax synthase activities 
[18], were, respectively, cloned into pESC-URA plasmid 
for expression in yeast. It was found that the yeast strain 
expressing ws2 produced mostly FAEEs (18.2  mg/L), 
with a small proportion of FABEs (1.85 mg/L) and FAIEs 
(2.21  mg/L) produced (Fig.  2). On the other hand, the 
yeast strain expressing Maqu_0168 resulted in a large 
proportion of FAIEs (96.2 mg/L), less FAEEs (12.2 mg/L), 
and a small amount of FABEs (3.82  mg/L). Further, as 
shown from the gas chromatography mass spectrom-
etry (GC/MS) peaks (Fig. 2), the majority of the products 
were C16 and C18 fatty acid derived.
To determine whether having more alcohols pre-
sent in the culture medium can further boost FASBEs 
product levels, 0.1  % ethanol, isobutanol or isoamyl 
alcohol was added exogenously. Additional file  1: 
Figure S1A shows that for the yeast strain express-
ing ws2, additional ethanol did not result in increased 
FAEEs titers, whereas additional isobutanol and isoa-
myl alcohol did result in ninefold increase in FABEs 
and FAIEs product titers, respectively. Therefore, 
while ethanol is not rate limiting in the yeast strains 
expressing ws2 for FAEEs production, isobutanol and 
isoamyl alcohol levels are rate limiting for FABEs and 
FAIEs production. Additional file 1: Figure S1B shows 
that for the yeast strain expressing Maqu_0168, nei-
ther exogenous ethanol nor isoamyl alcohol resulted 
in increased FAEEs or FAIEs titers, respectively, 
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whereas additional isobutanol increased FABEs levels 
by eightfold. Hence, both ethanol and isoamyl alco-
hol are not rate limiting in the yeast strain expressing 
Maqu_0168, but isobutanol is rate limiting for FABEs 
production. In addition, this result indicates that 
Maqu_0168 has higher affinity for isoamyl alcohol 
compared to ws2.
Deletion of INO1 negative regulators to boost FASBEs 
production
Towards engineering yeast strains that produce high lev-
els of fatty acid esters, we deleted two genes that are INO1 
negative regulators, namely RPD3 and OPI1. Deletion of 
both genes was shown previously to boost phospholipid 
production in yeast, and simultaneously boost fatty acyl-
CoA derived fatty alcohol titers [15]. Figure 3 shows the 
production of FAEEs, FABEs, FAIEs and total FASBEs 
in the yeast strains and mutants expressing ws2 over a 
period of 168 h. Fermentation of yeast was followed up to 
168 h to enable yeast cells to biosynthesize and accumu-
late more products. Here, we use values obtained at 168 
h to discuss the production levels of FABSEs. While pro-
duction of FABEs and FAIEs is low in the wild-type strain 
(2.0  mg/L for FABEs and 2.1  mg/L for FAIEs), FAEEs 
production was higher at 14.0  mg/L. When OPI1 was 
deleted, the production of FAEEs increased 2.7-fold to 
38.0 mg/L. However, deletion of RPD3 reduced fatty acid 
esters production, as opposed to the case for fatty alcohol 
production [15]. By carrying out a phospholipid assay, we 
found that indeed under our test conditions, OPI1 dele-
tion increased phospholipid levels whereas RPD3 dele-
tion decreased phospholipid levels (Additional file  1: 
Figure S3). This is possibly due to a difference in growth 
conditions, where glucose was used as carbon source in 
the previous report, while here, we have used galactose 
as inducer of protein expression and carbon source for 
growth. In the OPI1 knockout strain, a total FASBEs titer 
of 43.9 mg/L was obtained.
Figure  4 shows the production of FAEEs, FABEs, 
FAIEs, and total FASBEs in the yeast strains and mutants 
expressing Maqu_0168 over a period of 168 h. Here, the 
production of FAEEs and FABEs is low in the wild-type 
strain (11.3  mg/L for FAEEs and 3.4  mg/L for FABEs) 
compared to the production of FAIEs (95.6  mg/L). The 
total FASBEs produced was 110.3  mg/L. Also, it was 
Fig. 1 Metabolic engineering strategy to produce FASBEs. FAS‑
BEs can be produced by expressing a wax ester synthase (ws2 or 
Maqu_0168). Isobutanol pathway enzymes (Ilv2, Ilv5, Ilv3, Aro10, 
Adh7) were overexpressed in the mitochondria to accumulate more 
isobutanol and FABEs. At the same time, production of isoamyl 
alcohol and active amyl alcohols were also increased, resulting in 
increased FAIEs and FAAEs production. To boost FASBEs production, 
negative regulators of INO1 (Opi1, Rpd3) were deleted. Genes overex‑
pressed are shown in green. Red crosses gene deletions
Fig. 2 Substrate preference of the wax ester synthases. a Representative GC/MS result of FASBEs produced in BY4742 expressing ws2 or 
Maqu_0168. b Corresponding FASBEs titers. Values are the mean of biological triplicates ±SD after 48 h
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found that deletion of OPI1 and RPD3 both resulted in 
reduced FASBEs production levels. As the production 
of fatty acid esters requires two substrates, fatty acyl-
CoA and alcohol, a possible explanation is that deletion 
of OPI1 caused a reduction in isoamyl alcohol levels. 
This was confirmed by quantifying alcohol levels, where 
BY4742 opi1Δ (45.0 mg/L) had lower isoamyl alcohol lev-
els compared to BY4742 (64.3 mg/L) (Table 1).
Both Figs. 3 and 4 show that fatty acid ester titers were 
comparable at 48, 96 and 168 h. This suggests that pro-
duction of FASBEs occurs mainly during cell growth 
stage, and is greatly reduced or stopped in stationary 
phase (Additional file  1: Figure S5). In addition, FAEEs 
titers were higher at 48 h and decreased after that, sug-
gesting that FAEEs may have diffused out of the cell, or 
possibly degraded. However, extraction of products in 
the medium did not yield any FAEEs, indicating that 
most FAEEs were intracellular, while extracellular FAEEs 
had likely evaporated. Similarly, no FABEs or FAIEs were 
detected in the medium.
Boosting FABEs production
As seen in Figs. 3 and 4, the production of FABEs is mini-
mal. Hence, to boost FABEs production, genes that ena-
ble the production and accumulation of isobutanol need 
to be expressed in yeast. Here, we obtained a yeast strain 
(BY4742-IB) that has five isobutanol pathway enzymes 
(Ilv2, Ilv5, Ilv3, Aro10 and Adh7) overexpressed in the 
mitochondria of yeast to supply the required isobutanol 
[17]. This strain was constructed through integration of 
expression cassettes into δ-sites of retrotransposon ele-
ments of yeast chromosomes. Isobutanol produced is 
naturally transported out from the mitochondria into the 
cytoplasm where synthesis of FASBEs takes place. The 
increased isobutanol production was confirmed where an 
18-fold increase to 176.6 mg/L isobutanol was obtained 
compared to BY4742 (9.61 mg/L) (Table 1).
We then expressed ws2 and Maqu_0168 wax ester 
synthases in BY4742-IB and its OPI1 knockout mutant 
(Fig. 5). A RPD3 knockout mutant was not used because 
RPD3 deletion did not increase FASBEs production in 
BY4742. BY4742-IB expressing ws2 produced 49.3 mg/L 
FABEs, whereas BY4742-IB expressing Maqu_0168 
produced 26.6  mg/L FABEs. Also, the deletion of OPI1 
increased the amount of FABEs produced for both ws2 
and Maqu_0168 expressing strains to 69.8 and 30.2 mg/L, 
respectively.
At the same time, in BY4742-IB strains, FAAEs were also 
accumulated when active amyl alcohols levels were pro-
duced (Table 1). The production of active amyl alcohol is 
a result of overlapping synthesis pathway with the isobu-
tanol producing pathway [16]. FAAEs were not detected in 
wild-type BY4742 strain due to the absence of active amyl 
Fig. 3 Production of a FAEEs, b FABEs, c FAIEs and d Total FASBEs, in 
BY4742 and knockout strains of INO1 negative regulators (rpd3Δ and 
opi1Δ) expressing wax ester synthase ws2. All strains were cultured in 
minimal medium lacking uracil with 0.2 % glucose and 1.8 % galac‑
tose. Values are the mean of biological triplicates ±SD at 0, 48, 96, and 
168 h. Figures with adjusted y‑axis scales for (b) and (c) are shown in 
Additional file 1: Figure S2
Fig. 4 Production of a FAEEs, b FABEs, c FAIEs and d Total FASBEs, in 
BY4742 and knockout strains of INO1 negative regulators (rpd3Δ and 
opi1Δ) expressing wax ester synthase Maqu_0168. All strains were 
cultured in minimal medium lacking uracil with 0.2 % glucose and 
1.8 % galactose. Values are the mean of biological triplicates ±SD at 0, 
48, 96, and 168 h. Figures with adjusted y‑axis scales for (a) and (b) are 
shown in Additional file 1: Figure S4
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alcohol. In BY4742-IB opi1Δ expressing ws2, 4.25  mg/L 
FAAEs were produced, whereas 3.01  mg/L FAAEs were 
obtained when Maqu_0168 was expressed. FAIEs were 
the major fatty acid amyl esters produced, where produc-
tion levels of FAIE for BY4742-IB opi1Δ expressing ws2 
and Maqu_0168 were 9.6  mg/L and 68.7  mg/L, respec-
tively. For FAEEs, 32.4 mg/L was produced in BY4742-IB 
opi1Δ expressing ws2, whereas 8.3  mg/L was produced 
in BY4742-IB opi1Δ expressing Maqu_0168. The total 
FASBEs produced increased for both ws2 (83.2  mg/L to 
116.1 mg/L) and Maqu_0168 (102.0 mg/L to 110.2 mg/L) 
expressing OPI1 mutant strains.
In addition, isoamyl alcohol concentration was found 
to be boosted more than 35 % for both BY4742-IB opi1Δ 
(87.2  mg/L) and BY4742-IB (90.1  mg/L) compared to 
BY4742 strain (64.3 mg/L) (Table 1). Indeed, the expres-
sion of the isobutanol pathway enzymes can also boost 
isoamyl alcohol levels, also as a result of overlapping syn-
thesis pathway with the isobutanol producing pathway.
High‑cell‑density fermentation for FASBEs production
We next characterized four best strains for produc-
tion of FASBEs using high-cell-density fermentation. 
High-cell-density fermentation would allow rapid and 
more efficient conversion of sugars into desired prod-
ucts [15]. Cells were inoculated with initial OD600 of 9 
(Additional file  1: Figure S6). Figure  6 and Additional 
file  1: Figure S7 shows that yeast strain BY4742 opi1Δ 
expressing ws2 produced 33.4  mg/L FAEEs, 16.2  mg/L 
FABEs and 15.9 mg/L FAIEs, giving a total of 65.5 mg/L 
FASBEs (15.9  mg/gDCW). Yeast strain BY4742 
expressing Maqu_0168 produced 16.9  mg/L FAEEs, 
15.8  mg/L FABEs and 128.1  mg/L FAIEs, giving a total 
of 160.8  mg/L FASBEs (30.2  mg/gDCW). Yeast strain 
BY4742-IB opi1Δ expressing ws2 produced 16.9  mg/L 
FAEEs, 127.9  mg/L FABEs, 31.4  mg/L FAIEs and 
12.9 mg/L FAAEs, giving a total of 189.1 mg/L FASBEs 
(42.2 mg/gDCW). Yeast strain BY4742-IB opi1Δ express-
ing Maqu_0168 produced 9.43 mg/L FAEEs, 63.8 mg/L 
FABEs, 151.5  mg/L FAIEs and 9.48  mg/L FAAEs, giv-
ing a total of 234.2 mg/L FASBEs (50.9 mg/gDCW). The 
majority of FASBEs had fatty acid components of carbon 
chain lengths of C16 and C18, while esters with shorter 
chain length fatty acids were minor products. Strains 
expressing ws2 gave a higher proportion of longer chain 
FASBEs (fatty acid components of carbon chain lengths 
of C16 and C18, ~92  %), whereas for strains express-
ing Maqu_0168, the longer chain FASBEs proportion 
was ~80  %. In addition, strains expressing ws2 resulted 
in a product profile that had higher proportion of FAS-
BEs with saturated fatty acid components (~84 %) com-
pared to strains expressing Maqu_0168 which gave 
~77 % FASBEs with saturated fatty acid components. All 
Table 1 Alcohol production of engineered yeast strains. Values are the mean of biological triplicates ± standard devia-
tion after 48 h
Alcohols Strain
BY4742 BY4742 opi1Δ BY4742 rpd3Δ BY4742‑IB BY4742‑IB opi1Δ
Ethanol (g/L) 3.43 ± 0.24 7.17 ± 0.17 7.42 ± 0.45 4.39 ± 0.29 4.36 ± 0.11 
Isobutanol (mg/L) 9.61 ± 0.58 5.01 ± 0.62 11.6 ± 1.00 176.6 ± 9.54 178.1 ± 9.74
Isoamyl alcohol (mg/L) 64.3 ± 3.82 45.0 ± 2.20 68.6 ± 5.04 90.1 ± 2.91 87.2 ± 10.5
Active amyl alcohol (mg/L) 0.22 ± 0.05 0.13 ± 0.01 0.21 ± 0.01 25.2 ± 0.35 26.2 ± 3.66
Fig. 5 Production of a FAEEs, b FABEs, c FAIEs and FAAEs, and d 
Total FASBEs, in BY4742‑IB and BY4742‑IB opi1Δ expressing wax ester 
synthase ws2 or Maqu_0168. All strains were cultured in minimal 
medium lacking uracil and valine with 0.2 % glucose and 1.8 % 
galactose. Values are the mean of biological triplicates ±SD at 0, 48, 
96, and 168 h
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FASBEs with unsaturated fatty acid components were 
monounsaturated.
Conclusions
Concerns about limited supply of nonrenewable fossil 
fuels and the environmental impact of their usage con-
tinue to encourage discovery and development of renew-
able advanced biofuels, such as alcohols, alkanes, fatty 
acid esters and isoprenoids [19–23]. Recently, Liu and 
coworkers engineered Escherichia coli to produce fatty 
acid esters with short- and branched-chain alcohol moi-
eties from glycerol [22, 23]. Introduction of 2-keto acid 
pathway and metabolic engineering of the fatty acid path-
way together with expression of a wax ester synthase 
enzyme from Acinetobacter baylyi enabled production of 
a range of fatty acid esters, including ethyl, propyl, isobu-
tyl, butyl and isoamyl esters [22]. Further introduction 
of branched fatty acid biosynthetic pathway resulted in 
branched fatty acid branched-chain esters [23].
Here, we have engineered yeast S. cerevisiae to produce 
and accumulate FASBEs that can be used as biodiesel, 
including FAEEs, FABEs, FAIEs and FAAEs. However, 
challenges remain before large-scale bioproduction can 
be considered. First, even though we have produced 
up to 230  mg/L FASBEs, which is the highest reported 
fatty acid ester production titer in yeast to date, further 
manipulation of the cells through increase of intermedi-
ate supply and use of gene regulatory tools are required 
to maximize the production potential of yeast [24–27]. 
Second, the products were found to be accumulated 
intracellularly. Strategies for product recovery need to be 
developed to enable cell reuse [28, 29].
In this work, it was found that wax synthases ws2 and 
Maqu_0168 resulted in different product profiles where 
the former preferentially produced FAEEs, FABEs and 
FAAEs and the latter produced mostly FAIEs. In addi-
tion, more FABEs and FAIEs were produced compared 
to FAEEs, even though ethanol levels were much higher 
Fig. 6 High‑cell‑density fermentation for FASBEs production of different fatty acid chain lengths. Four strains were chosen for the fermentation: a 
BY4741 opi1Δ expressing ws2, b BY4742 expressing Maqu_0168, c BY4742‑IB opi1Δ expressing ws2 and d BY4742‑IB opi1Δ expressing Maqu_0168. 
All strains were cultured in minimal medium lacking appropriate amino acid and/or nucleotide with 2 % galactose at an initial OD600 of ~9. Values 
are the mean of biological triplicates ±SD at 48 h
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than the other alcohols (Table 1). This can be attributed 
to higher specific activity of wax synthases for longer 
chain alcohols [5, 18]. Hence, the identification and 
use of wax synthases according to substrate preference 
and desired products are crucial for improved biodiesel 
production.
In summary, we engineered yeast to produce FASBEs 
using endogenously synthesized fatty acids and alcohols. 
Two wax ester synthase genes (ws2 and Maqu_0168) 
were found to catalyze the formation of FASBEs, with dif-
ferent alcohol preferences. To boost the ability of yeast 
to produce the FASBEs, gene deletions (OPI1 and RPD3) 
were carried out to increase flux towards fatty acyl-CoAs. 
In addition, isobutanol pathway enzymes (Ilv2, Ilv5, Ilv3, 
Aro10 and Adh7) targeted into the mitochondria were 
overexpressed, producing branched alcohols for esteri-
fication. By combining these engineering strategies, and 
through high-cell-density fermentation, over 230  mg/L 
FASBEs were produced, which is the highest titer 
reported in yeast to date.
Methods
Yeast strains and media
The yeast strains used in this study were derived from S. 
cerevisiae strain BY4742 (MATα; his3Δ1; leu2Δ0; lys2Δ0; 
ura3Δ0) (ATCC, Manassas, VA, USA) (Table  2). Isobu-
tanol producing strain M12 derived from BY4742 was a 
gift from Dr. Jifeng Yuan (National University of Singa-
pore). Plasmids used are listed in Table  3. DNA prim-
ers used for PCR are listed in Additional file  1: Table 
S1. E. coli strain Top10 was used for transformation 
and amplification of plasmids, grown at 37  °C in Luria–
Bertani broth supplemented with 100  μg/mL ampicil-
lin. Yeast extract and peptone were obtained from BD 
(Franklin Lakes, NJ, USA), whereas other chemicals were 
purchased from Sigma Aldrich (St. Louis, MO, USA), 
unless otherwise stated. Yeast strains were grown in min-
imal medium (yeast nitrogen base 6.7 g/L, yeast synthetic 
drop-out medium supplements—Ura- 1.92  g/L, d-glu-
cose 20 g/L) at 30 °C with 225 rpm shaking.
Cloning procedures
Restriction enzymes used were procured from New Eng-
land Biolabs (Ipswich, MA, USA) and digestions were 
conducted according to the recommended protocols. 
PCR amplifications were performed with iProof High 
Fidelity DNA Polymerase (Bio-Rad, Hercules, CA, USA) 
at suggested conditions. Ligations were carried out with 
T4 DNA Ligase (New England Biolabs) at 16  °C. Gel 
extractions were performed using QIAquick gel extrac-
tion kit (Qiagen, Venlo, The Netherlands). Minipreps of 
plasmids from E. coli were carried out using QIAprep 
Spin Miniprep kit. Standard chemical transformation 
methods for E. coli were applied for transformation of 
ligation mixtures. The LiAc/PEG technique was used for 
transformation of yeast cells.
Plasmids and yeast knockout strains construction
To construct plasmids expressing wax ester synthase 
proteins, genes ws2 and Maqu_0168 were codon opti-
mized and synthesized using GeneArt (Life Technolo-
gies, Carlsbad, CA, USA) (Additional file  1: Table S2). 
Table 2 Strains used in this study
Strains Genotype Source
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 EUROSCARF
BY4742‑IB BY4742 with isobutanol pathway integrated Yuan and Ching [17]
pESC BY4742 BY4742 (pESC‑URA) This work
pESC BY4742‑IB BY4742‑IB (pESC‑URA) This work
ws2 BY4742 BY4742 (pESC‑GAL10p‑ws2) This work
Maqu_0168 BY4742 BY4742 (pESC‑GAL10p‑Maqu_0168) This work
ws2 BY4742‑IB BY4742‑IB (pESC‑GAL10p‑ws2) This work
Maqu_0168 BY4742‑IB BY4742‑IB (pESC‑GAL10p‑Maqu_0168) This work
BY4742 rpd3Δ rpd3Δ::kanMX derived from BY4742 This work
BY4742 opi1Δ opi1Δ::kanMX derived from BY4742 This work
BY4742‑IB opi1Δ opi1Δ::kanMX derived from BY4742‑IB This work
ws2 BY4742 rpd3Δ BY4742 rpd3Δ (pESC‑GAL10p‑ws2) This work
Maqu_0168 BY4742 rpd3Δ BY4742 rpd3Δ (pESC‑GAL10p‑Maqu_0168) This work
ws2 BY4742 opi1Δ BY4742 opi1Δ (pESC‑GAL10p‑ws2) This work
Maqu_0168 BY4742 opi1Δ BY4742 opi1Δ (pESC‑GAL10p‑Maqu_0168) This work
ws2 BY4742‑IB opi1Δ BY4742‑IB opi1Δ (pESC‑GAL10p‑ws2) This work
Maqu_0168 BY4742‑IB opi1Δ BY4742‑IB opi1Δ (pESC‑GAL10p‑Maqu_0168) This work
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PCR was carried out using primers ws-f-EcoRI and ws-
r-NotI for ws2 and Maqu-f-EcoRI and Maqu-r-NotI for 
Maqu_0168. The PCR products were then gel extracted 
and digested using EcoRI and NotI, and ligated into 
pESC-URA, also digested with the same enzymes. Cor-
rect clones were confirmed by colony PCR and plasmid 
sequencing.
To create yeast knockout strains, gene deletion cas-
settes were amplified using PCR with primers as shown 
in Additional file 1: Table S1 and pUG6 as the template. 
The deletion cassettes were then transformed into yeast 
strains and screened on YPD plates containing 200  μg/
mL G418 and verified by PCR.
Growth parameters of engineered strains including 
growth rate and yield of biomass are shown in Additional 
file  1: Table S3. Dry cell weight (DCW) was calculated 
from the optical density at 600  nm (1 OD600  =  0.262 
gDCW/L).
Determining FASBEs production
For quantifying FASBEs produced in different engineered 
yeast strains, single colonies were pre-cultured overnight 
in 3 mL minimal medium with glucose as carbon source. 
The cells were then inoculated into 50 mL fresh minimal 
medium with 1.8 % galactose and 0.2 % glucose in 250 mL 
glass flasks at an initial OD600 of 0.05. At the stated time 
points, fatty acid esters were extracted and quantified as 
follows. Cells (2.5 mL) were centrifuged and the superna-
tant decanted, and 0.5 mL of autoclaved water was added 
to re-suspend the cells. Next, the cells were transferred 
to a 2  mL Fastprep tube (MP Biomedicals, Santa Ana, 
CA, USA) added with 0.3  g glass beads (425–600  μm). 
The cells were lyzed using a Fastprep-24 homogenizer, 
at 6 m/s for 30 s, put on ice for 2 min and repeated for 
10 times. Hexane (0.5 mL) spiked with methyl heptade-
canoate as internal standard was then added to the lysed 
cells, followed by vigorous vortex to extract the fatty acid 
esters. The mixture was centrifuged at maximum speed 
to separate aqueous and organic layers, where 200 μL of 
product containing hexane was transferred to GC vials 
for quantification. GC/MS (7890B GC system, 5977A 
MSD, Agilent Technologies, Santa Clara, CA, USA) 
analysis was carried out with a HP-5 ms column (Agilent 
Technologies) with a 0.25  μm film thickness, 0.25  mm 
diameter, and 30 m length. The GC program was set as 
follows: an initial temperature of 45  °C was maintained 
for 1.5  min, followed by ramping to 180  °C at a rate of 
15 °C/min, where it was held for 3 min. The temperature 
was then ramped to 280 °C at a rate of 10 °C/min, where 
the temperature was held for 5 min.
Determining alcohol levels and phospholipid content
To quantify alcohols produced by the engineered yeast 
strains, single colonies were pre-cultured overnight in 
1  mL minimal medium with glucose as carbon source. 
The cells were then inoculated into 5 mL fresh minimal 
medium with 1.8 % galactose and 0.2 % glucose in 50 mL 
tubes at an initial OD600 of 0.05. After 48 h growth, alco-
hols were extracted as follows. Cell culture (0.5 mL) was 
transferred to a clean 1.5  mL tube, and 0.5  mL hexane 
spiked with 1-butanol as internal standard was then 
added to the cells, followed by vigorous vortex to extract 
the alcohols. The mixture was then centrifuged at maxi-
mum speed to separate aqueous and organic layers, 
where 300  μL of alcohol containing hexane was trans-
ferred to GC vials for quantification. GC/MS analysis was 
carried out with a DB-FFAP column (Agilent Technolo-
gies) with a 0.25  μm film thickness, 0.25  mm diameter, 
and 30 m length. The GC program was set as follows: an 
initial temperature of 45  °C was maintained for 15 min, 
followed by ramping to 240  °C at a rate of 30  °C/min, 
where it was held for 3 min. To analyze the phospholipid 
concentration, yeast cells were centrifuged and washed 
with autoclaved deionized water, followed using a phos-
pholipid assay kit (Abnova, Taipei, Taiwan) to determine 
the concentration of phospholipids according to the 
manufacturer’s instructions.
High‑cell‑density fermentation for FASBEs production
To measure the production of FASBEs with fermenta-
tion at high cell density, single colonies of the engineered 
yeast strains were pre-cultured overnight in 3 mL mini-
mal medium with glucose as carbon source. The cells 
were then rediluted with 50  mL minimal medium with 
2 % glucose in 250 mL glass flasks at an initial OD600 of 
0.25 and grown for a further 24  h. Next, the cells were 
centrifuged and inoculated into 50  mL fresh minimal 
media with 2 % galactose in 250 mL glass flasks (giving 
Table 3 Plasmids used in this study
Plasmids Description Source
pUG6 Plasmid containing loxP‑kanMX‑loxP deletion cassette EUROSCARF
pESC‑URA 2μ plasmid (URA marker) Agilent
pESC‑GAL10p‑ws2 pESC‑URA with ws2 cloned in This work
pESC‑GAL10p‑Maqu_0168 pESC‑URA with Maqu_0168 cloned in This work
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an initial OD600 of ~9). After 48 h culture, 2.5 mL of each 
sample was centrifuged and the FASBEs extracted and 
quantified as described for FASBEs above.
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